Home / Middle East / United Arab Emirates / Life Sciences & Healthcare

Life Sciences & Healthcare

Dubai’s vision to become a hub for healthcare tourism, the rapid expansion of local and expat populations across the Middle East, as well as the region’s unique demographics, give rise to opportunities and challenges for investors in the lifesciences and healthcare sectors.

We work with and have established long-term relationships with the top 100 lifesciences companies in the areas of pharmaceuticals, medical devices, biotechnology, agriculture and food, including the top 20 global pharmaceutical companies and nine out of the top ten global medical device companies.  We also support clinics, hospitals, and other service providers active in the healthcare sector, and private investors in such businesses, across the Middle East. Our experts advise leading global business groups in the sector on transactions, commercial agreements, compliance, investigations and litigation, very often across multiple jurisdictions in the region and beyond. We can help you to navigate the regulatory landscape and to ensure compliance with both local laws and global policies.

With over 480 international specialist lawyers across CMS, we understand the scientific and commercial as well as the legal imperatives affecting your lifesciences and healthcare businesses. Our experts, many of whom have worked in-house in your sector, have developed a shared capability in the areas of pharmaceuticals, biotechnology, medical devices and diagnostics. With active memberships in major industry associations such as the ABPI, ABHI, BIVDA, PAGB, EUCOMED and EFPIA, we help shape the legal frameworks impacting the lifesciences sector. We regularly advise our clients on their day-to-day operational needs such as support with advertisement and promotion of medicine, public sector procurement, pricing and reimbursement, patent enforcement, commercial and clinical trial agreements as well as regulatory advice.

Highlights of our experience in Lifesciences in UAE
An International Healthcare Services provider on its contract for the provision of healthcare services to the UAE MilitaryZentiva NV on its acquisition of 75% of Eczacibasi Generic Pharmaceuticals in...

Feed

25/04/2024
Pharmaceutical advertising regulation and medical device advertising in...
1. Which laws are applicable regarding advertising of medicines and medical devices? Federal Law No.8/2019 on Medical Products, Profession of Pharmacy and Pharmaceutical Institutions (“2019 Law”)...
27/03/2024
Cannabis law and legislation in the UAE
Medical use Cannabis possession is illegal in the United Arab Emirates. Article 7 of Law No 14 of 1995 and its amendments (the Anti-Narcotic Psychotropic Substances Law) provides that “except in the...
08/12/2023
COP28: Global Health Under the Spotlight
Health took centre stage at the first ever ‘Health Day’ at COP28 on 3 December. The program focused the attention of world leaders on the profound public health-related issues stemming from climate...
01/06/2022
CMS Next
What’s next? In a world of ever-ac­cel­er­at­ing change, staying ahead of the curve and knowing what’s next for your business or sector is essential. At CMS, we see ourselves not only as your legal advisers but also as your business partners. We work together with you to not only resolve current issues but to anticipate future challenges and innovate to meet them. With our latest publication, CMS Next, our experts will regularly offer you insights into and fresh perspectives on a range of issues that businesses have to deal with – from ESG agendas to restructuring after the pandemic or facing the digital transformation. We will also share with you more about the work that we are doing for our clients, helping them innovate, grow and mitigate risk. To be able to provide you with the best support, we immerse ourselves in your world to understand your legal needs and challenges. However, it is equally important that you know who we are and how we can work with you. So, we invite you to meet our experts and catch a glimpse of what is happening inside CMS. Enjoy reading this publication, which we will update regularly with new content. CMS Executive Team
26/11/2021
CMS On the Pulse episode #10:  Digital Health law, regulations and developments...
The Global Life Sciences & Healthcare Sector Group, along with the Lifesciences Asia-Pacific Network (LAN), are delighted to release the latest episode in its video/podcast series, On the Pulse. The series...
24/11/2021
On the Pulse
Welcome to CMS ‘On the Pulse’ video/podcast series for all Life Sciences & Healthcare professionals – legal, compliance, regulatory
04/11/2021
Update: CMS Expert Guide to International Arbitration – Americas
We are pleased to announce that the fifth volume of the CMS Expert Guide to International Arbitration has been published, covering seven jurisdictions in the Americas: Argentina, Brazil, Columbia, Chile...
22/06/2021
UAE Health Data – new data transfer permissions
In 2019, UAE healthcare providers and other businesses involved in the industry were prevented from transferring outside the country data related to medical procedures in the UAE, by Article 13 of Federal...
09/06/2021
Open secrets? Guarding value in the intangible economy
We are delighted to share with you the report commissioned by CMS and written by The Economist Intelligence Unit. It explores the extent to which firms identify intangible assets as trade secrets and...
07/06/2021
CMS On the Pulse episode #9: A focus on compulsory licensing for phar­ma­ceut­ic­al...
The Global Life Sciences & Healthcare Sector Group is delighted to release the latest episode in its video/podcast series, On the Pulse. The series brings together CMS lawyers and experts to discuss key...
01/06/2021
Some leaks can't be fixed
“Confidential information is like an ice cube... give it to the party who has no refrigerator or will not agree to keep it in one, and by the time of the trial you have just a pool of water.” This...
29/04/2021
Updated CMS Expert Guide to A legal roadmap for Cannabis
2021 is shaping up to be a year of significant developments for the cannabis industry around the globe. Some countries have reformed their regulations on medical cannabis. In January 2021, a set of Rules...